Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Gold: $6,600 or $22,000

I like to read. I read fast and that helps. I can't quite come to grips with all these guys now coming out with 25-minute videos they insist we watch instead of reading. Do they really believe that everyone has so much free time that they can pay attention to someone ch...
Streetwise Reports | May 4, 2020 |

Paratek Pharma Awarded $285 Million BARDA Contract to Combat Anthrax

Shares of Paratek Pharmaceuticals traded 40% higher today after the firm announced it was awarded a BARDA BioShield program contract valued at up to $285 million for NUZYRA used to treat anthrax. Late yesterday afternoon, biopharmaceutical company Paratek Pharmaceuti...
Streetwise Reports | December 20, 2019 |

The 2019 Benzinga Cannabis Capital Conference: Everything You Missed In Miami Beach

With the warm, sunny backdrop of Miami Beach, the second iteration of the Benzinga Cannabis Capital Conference filled every seat with enthusiastic and proactive investors who are looking for their next deal in a budding landscape. “Every single person in this room is ...
Hannah Genig | April 1, 2019 |

Gold's Epochal Breakout Will Not Be Negated by a Correction

Technical analyst Clive Maund charts the reasons why the recent gold breakout is genuine. It has been a truly glorious month for gold, and the purpose of this update is to point out firstly that the gold breakout of the past week was genuine and secondly tha...
Streetwise Reports | July 3, 2019 |

The Impossible Recession in the World’s Playground

Over the last six months, it has become very apparent that our global economy is changing. Yet most investors seem entirely complacent. FTD’s ™, aka Financially Transmitted Diseases , will start to appear and be used more frequently. And the policym...
Marin Katusa | September 6, 2019 |

Huge Unemployment Is Coming. Will It Push Gold Prices Up?

On Thursday, the initial jobless claims rocketed to almost 3.3 million. Quite an unimaginable number. What does it imply for the US economy and the gold market? One of the Most Scariest Things You Will See This Week Would you like to see something scary? I guess not, b...
Arkadiusz Sieron | March 31, 2020 |

How to Unrig the Gold Market, According to GATA’s Chris Powell

In an earlier post, I gave you a sneak preview of my interview with Chris Powell, secretary/treasurer at Gold Anti-Trust Action Committee (GATA). For 20 years now, Chris and others at GATA have made it their mission to expose collusion by international financial institutions...
Frank Holmes | May 22, 2019 |

5 Most Profitable Stocks of Tech Companies in 2019

Apple stocks make up 23.4% of Warren Buffett’s portfolio. He is the most famous and successful money manager of the present days, whose tips and advice are highly embraced by investors. He is the fourth-richest person in the world with a net worth of over $80...
Julia Beyers | November 4, 2019 |

Plus Therapeutics Shares Trade Higher on Q3 Earnings and Business Restructuring

Plus Therapeutics shares opened 25% higher today after the firm reported Q3/19 financial and business results. In the most recent quarter, the company completed the change of its name, relocated its headquarters to Austin, and raised $15 million for R&D and working capital. ...
Streetwise Reports | November 18, 2019 |

Applied Genetic Tech's Shares Double on 6-Month X-Linked RP Study Results

Shares of Applied Genetic Technologies skyrocketed to a new 52-week high price after the company reported positive six-month data from its ongoing Phase 1/2 clinical study for treatment in X-Linked Retinitis Pigmentosa. The firm stated that the trial data suggests durable and ...
Streetwise Reports | January 10, 2020 |
1 2 3 4 5 6